Literature DB >> 29278408

Botulinum hemagglutinin-mediated in situ break-up of human induced pluripotent stem cell aggregates for high-density suspension culture.

Suman C Nath1, Tomohiro Tokura1,2, Mee-Hae Kim1, Masahiro Kino-Oka1.   

Abstract

Large numbers of human induced pluripotent stem cells (hiPSCs) are required for making stable cell bank. Although suspension culture yields high cell numbers, there remain unresolved challenges for obtaining high-density of hiPSCs because large size aggregates exhibit low growth rates. Here, we established a simple method for hiPSC aggregate break-up using botulinum hemagglutinin (HA), which specifically bound with E-cadherin and disrupted cell-cell connections in hiPSC aggregates. HA showed temporary activity for disrupting the E-cadherin-mediated cell-cell connections to facilitate the break-up of aggregates into small sizes only 9 hr after HA addition. The transportation of HA into the aggregates was mediated by transcellular and paracellular way after HA addition to the culture medium. hiPSC aggregates broken up by HA showed a higher number of live cells, higher cell density, and higher expansion fold compared to those of aggregates dissociated with enzymatic digestion. Moreover, a maximum cell density of 4.5 ± 0.2 × 106 cells ml-1 was obtained by aggregate break-up into small ones, which was three times higher than that with the conventional culture without aggregate break-up. Therefore, the temporary activity of HA for disrupting E-cadherin-mediated cell-cell connection was key to establishing a simple in situ method for hiPSC aggregate break-up in bioreactors, leading to high cell density in suspension culture.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  botulinum hemagglutinin; high-density culture; human induced pluripotent stem cells; in situ aggregate break-up; suspension culture; temporal E-cadherin disruption

Mesh:

Substances:

Year:  2018        PMID: 29278408     DOI: 10.1002/bit.26526

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  4 in total

Review 1.  Cell-Based Therapy Manufacturing in Stirred Suspension Bioreactor: Thoughts for cGMP Compliance.

Authors:  Suman C Nath; Lane Harper; Derrick E Rancourt
Journal:  Front Bioeng Biotechnol       Date:  2020-11-26

2.  Approach of resource expenditure estimation toward mechanization in the manufacturing of cell-based products.

Authors:  Manabu Mizutani; Kentaro Nakajima; Masahiro Kino-Oka
Journal:  Regen Ther       Date:  2022-03-10       Impact factor: 3.419

3.  Adequate taylor couette flow-mediated shear stress is useful for dissociating human iPS cell-derived cell aggregates.

Authors:  Katsuhisa Matsuura; Masanori Wada; Katsuhisa Sakaguchi; Yuki Matsuhashi; Tatsuya Shimizu
Journal:  Regen Ther       Date:  2019-04-25       Impact factor: 3.419

4.  Kinetic modeling of human induced pluripotent stem cell expansion in suspension culture.

Authors:  Vytautas Galvanauskas; Rimvydas Simutis; Suman Chandra Nath; Masahiro Kino-Oka
Journal:  Regen Ther       Date:  2019-04-25       Impact factor: 3.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.